Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study

2015 ◽  
Vol 20 (1) ◽  
pp. 73-77 ◽  
Author(s):  
Preeti Tiwari ◽  
Vaibhav Pandey ◽  
Ajay N. Gangopadhyay ◽  
Shiv P. Sharma ◽  
Dinesh K. Gupta
2016 ◽  
Vol 88 (4) ◽  
pp. 219-224 ◽  
Author(s):  
Chandrakant Munjewar ◽  
Ishaq Nabi ◽  
Santosh Gautam ◽  
Neelam Ahirwar ◽  
Poras Chaudhary ◽  
...  

2018 ◽  
Vol 37 (4) ◽  
pp. 191-196 ◽  
Author(s):  
A. Alikhassi ◽  
Sh. F. Hamidpour ◽  
M. Firouzmand ◽  
M. Navid ◽  
M. Eghbal

2000 ◽  
Vol 32 (5) ◽  
pp. 941-953 ◽  
Author(s):  
James G. Chandler ◽  
Olivier Pichot ◽  
Carmine Sessa ◽  
Sanja Schuller-Petrović ◽  
Francisco José Osse ◽  
...  

2021 ◽  
pp. 026835552110023
Author(s):  
Christos S Karathanos ◽  
Konstantinos Batzalexis ◽  
Petroula Nana ◽  
Konstantinos Spanos ◽  
George Kouvelos ◽  
...  

Objectives The aim of our study was to evaluate the role of flavonoids in the improvement of post-operative symptoms after endovenous thermal ablation (EVTA). Methods A prospective comparative study of 120 consecutive patients undergoing EVTA of the greater saphenous vein associated with phlebectomies was undertaken. Patients were grouped in those receiving micronized purified flavonoid fraction (MPFF- 60 patients) agent 500 mg Bid 7 days pre- and 30 days post- operatively (MPFF group) and those in the control group (60 patients) who did not. Demographics, intra-operative details, Clinical –Etiology- Anatomy- Pathophysiology (CEAP) clinical class, 10-cm Visual Analog Scale (VAS) for pain, Venous Clinical Severity Score (VCSS) and Chronic Venous Insufficiency Quality-of-Life Questionnaire (CΙVIQ-20) were recorded. Primary outcome was the postoperative pain assessement using the VAS scale and CIVIQ pain score. Secondary outcomes included assessement of VCSS and CΙVIQ-20 scores. Results There were no significant differences between the groups regarding demographics, clinical and procedural characteristics. Patients in MPFF group reported significantly lower VAS pain levels than control group at 7- (−3.6 ± 1.2 vs −2.7 ± 1.9, p < .0001) and 30- post-operative day (−4.9 ± 0.1 vs −4.2 ± 1, p < .0001). MPFF group also showed better outcome in terms of CIVIQ pain score at 7- (−3.7 ± 1.3 vs −3.5 ± 1.8, p = .008) and 30- post-operative day (−5.3. ± 1.1 vs −4.4 ± 1, p = .017). Both groups showed a significant improvement in VAS pain score (p = .047), global CIVIQ-20 (p = .009) and VCSS (p = .008) at 7- and 30-days post-operatively. Conclusions Administration of flavonoids in patients undergoing EVTA associated with phlebectomies reduces pain by a small amount during early postoperative period.


Sign in / Sign up

Export Citation Format

Share Document